The definition of the ADM.Sample.general_sample_pathology element suggests that the subject of the observation here is the anatomic source of the specimen, not the specimen itself (what type of tissue the specimen was derived/taken from):
"An indicator as to whether a sample is derived from normal or tumor-bearing tissue."
Is there any way in BRIDG to represent the anatomical source/tissue as the subject of the observation here? i.e. can we represent the source tissue in the organism as a specimen, that is separate from the extracted specimen - an observed specimen in situ vs an extracted material specimen in vitro)
And more generally, for all elements classified as being about anatomic source/biological source . . . should the mapping path for these make the subject of observations (and perhaps the root of the Mapping path) be the source material, not the specimen (if we consider the specimen to be the material once taken out of the source)
Here are a list of elements in Sample that I would say are about this anatomical source, rather than the specimen itself:
- biospecimen anatomic site
- biospecimen laterality
- distance to normal tumor
- general sample pathology
- tissue type
- sample type
- sample type id
Another general issue this may raise is the distinction between observations about a samples made during collection (while it is still in vivo), as being distinct from observations made after extraction, typically by a pathologist, that may confirm (or refute or extend or qualify) the observation that was made earlier during extraction. This is a common phenomenon, and we need a clear and consistent way to represent it. Being able to represent the anatomic source of a specimen separately from the extracted specimen would be one way to support this (assuming there is a way to capture the derivation relationship between them)
The definition of the
ADM.Sample.general_sample_pathologyelement suggests that the subject of the observation here is the anatomic source of the specimen, not the specimen itself (what type of tissue the specimen was derived/taken from):Is there any way in BRIDG to represent the anatomical source/tissue as the subject of the observation here? i.e. can we represent the source tissue in the organism as a specimen, that is separate from the extracted specimen - an observed specimen in situ vs an extracted material specimen in vitro)
And more generally, for all elements classified as being about anatomic source/biological source . . . should the mapping path for these make the subject of observations (and perhaps the root of the Mapping path) be the source material, not the specimen (if we consider the specimen to be the material once taken out of the source)
Here are a list of elements in Sample that I would say are about this anatomical source, rather than the specimen itself:
Another general issue this may raise is the distinction between observations about a samples made during collection (while it is still in vivo), as being distinct from observations made after extraction, typically by a pathologist, that may confirm (or refute or extend or qualify) the observation that was made earlier during extraction. This is a common phenomenon, and we need a clear and consistent way to represent it. Being able to represent the anatomic source of a specimen separately from the extracted specimen would be one way to support this (assuming there is a way to capture the derivation relationship between them)